Hypertension study in anaesthetized rabbits: protocol proposal for AT1 antagonists screening

Area of Science:

• Pharmacology
• Cardiovascular Research
• Drug Discovery

Background:

• Developing efficient methods for screening AT(1) receptor antagonists is crucial for cardiovascular drug development.
• Existing protocols may lack speed, safety, or optimal dose efficiency.

Purpose of the Study:

• To establish an optimized, fast, and safe protocol for the pharmacological screening of AT(1) antagonists.
• To validate the protocol using known AT(1) antagonists like losartan and its metabolite EXP3174.

Main Methods:

• Continuous infusion of Angiotensin II (Ang II) in animal models.
• Administration of AT(1) antagonists (losartan, EXP3174, MMK1) via single bolus or sequential doses.
• Evaluation of pressor responses to Ang II following antagonist administration in pre- and post-treatment procedures.

Main Results:

• Losartan bolus showed efficacy for 7 minutes; EXP3174 infusion extended efficacy throughout the study.
• Sequential losartan injections prolonged the inhibitory effect until the study's end.
• MMK1 did not alter the pressor response to Ang II, indicating its lack of AT(1) antagonism in this model.

Conclusions:

• The developed protocol is safe, simple, and rapid for pharmacological screening of AT(1) antagonists.
• This method enables the evaluation of novel antagonists at reduced doses compared to existing literature.
• The protocol facilitates efficient assessment of AT(1) antagonist efficacy and duration of action.